We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Beximco Pharma | LSE:BXP | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.00 | 2.63% | 39.00 | 38.00 | 40.00 | 39.00 | 38.00 | 38.00 | 189,997 | 15:33:18 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/10/2017 09:38 | Yes. Share price reaction muted, probably because BXP off most investors radar. | kenmitch | |
06/10/2017 08:50 | positive news today | mfhmfh | |
29/9/2017 15:40 | Perhaps Beximco aren't totally sure of just how good their distribution agents, and accordingly their sales people, are ? Better to check that out with smaller value/market size products first, to see if sales are generated, and how quickly. This before committing to supply large amounts of more valuable stock with perhaps a shorter shelf-life, which might, or might not, sell. | outsizeclothes.com | |
29/9/2017 15:15 | Are they fiddling around the edges of the smaller markets, to demonstrate to the authorities their competence?You are correct about the release numbers, but so little context, and zero feel for the future strategy... | zcaprd7 | |
03/8/2017 00:23 | $30m market is pathetic... | zcaprd7 | |
25/7/2017 10:26 | confirmation RNS for 4th drug today. 'along with our growing pipeline' suggests more approvals to come IMHO. | mfhmfh | |
24/7/2017 21:42 | Drug no. 4 approved by FDA, no RNS. | cockneytrader | |
12/7/2017 11:43 | I am very happy with this one i have the main part of this stock and i don't trade and i keep topping up when go to 54 and sell almost all i topped up every time get to 63 keep the profit in share so far as worked quite few times | jovi1 | |
28/6/2017 09:41 | Some actual news not just reports, there must be some fairly big ticket events happening that would be news worthy but they've released sweet FA for 6 months other than results. There needs to be something to get excited about to make it a worth while investment and they are giving us nothing hence the waning shareprice. | ginko3 | |
28/6/2017 00:01 | They report quarterly, what more do you want? | crazycoops | |
27/6/2017 13:17 | Its now been 6 months since any real news wtf is BXP doing, no wonder the share price performance is so lacklustre this year | ginko3 | |
20/6/2017 12:36 | Would hope to get confirmation shortly that they've launched the Metformin / Glucophage tablets through their distributor in the US and shortly thereafter, some indication of the level of take-up. | ginko3 | |
17/6/2017 14:06 | I'm also back in now albeit in a small way, didn't quite catch the bottom but in for 60p for just about in profit now; quite happy and able to sit it out for the long term. | ginko3 | |
17/6/2017 00:19 | Good shout... Keeping my powder dry at the moment though. | zcaprd7 | |
15/6/2017 18:17 | Couldn't believe 54p to BUY. So I'm back in here now. 50% discount??? - when there's been agitation for dividend payments to GDR holders? If they go ahead, we'll get one of the highest yields in the market. (about 12% here) Ave discount anyway over the past year has been under 40% (which is too much IMHO anyway). And the co is world class, so over time it's going higher. The mkt is certainly daft at times - delighted in this case! J | jswjsw | |
15/6/2017 17:07 | I bought in here on the dip. I've been waiting ages for a good entry price. great long-term ISA hold IMHO. GL all. | mfhmfh | |
15/6/2017 16:30 | no idea but I used to average down and pick up few at 53 and 54 the odd thing was that drop 10 point on a 37k share traded | jovi1 | |
15/6/2017 15:56 | Whoa! what just happened there? Minus 10p from nowhere | crazycoops | |
09/5/2017 13:56 | I'm sittin and waiting... big rise coming over the next 2 years... also buyout possibility so 0% discount to dhaka, plus more big paying drugs will be in the pipeline £2-£5 in next 2-3 years with very little risk. GLA | greg the grinch | |
02/5/2017 08:51 | Agreed. Decided to lock in my 70% gain. Will probably regret... | zcaprd7 | |
01/5/2017 19:01 | Based on the eps figure and historic prices, BXP is fair at BDT 103-108 (around £1 equivalent). 69p may seem like a big discount, but this has been around 45% for long periods. Over the past week or so this has narrowed to just over 30%, where it is probably fair, IMHO. Can't see the £ strengthening much more, but I worry slightly that Dhaka is retracing. So I sold on Fri - will buy back if we see BDT 100. j | jswjsw | |
01/5/2017 18:20 | Top-line growth and profit look OK but my concern would be that the company is not generating any FCF and hasn't consistently done so. Why are they paying a dividend if they are still investing so heavily in growth? BTW: look at their accounts on the website not the numbers on Stockopedia. (running down short-term investments doesn't count as FCF!) Doesn't mean it is a bad company but it pays to understand what is going on.. | jombaston | |
29/4/2017 21:40 | Figures look decent enough to me. A pity that the company provides figures and no real commentary on current trading or outlook. Certainly not a company that can be accused of over hyping it's prospects to investors! No negatives from Graham Neary and as he points out BXP has a very high stock rank on Stockopedia. I'm happy to keep running a long position here. Dibbs | dibbs | |
28/4/2017 14:08 | there is a brief write up in today's SCVR by Graham Neary | crazycoops |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions